Experts’ advice for people with diabetes, celebrating Match Day amid COVID-19 — top stories in endocrinology

Experts are warning patients with type 1 and type 2 diabetes of their increased susceptibility to COVID-19 and are recommending that they keep an adequate supply of medication to be better prepared. It was the top story in endocrinology last week.

Another top story was about how medical students are celebrating Match Day 2020 amid institutional shutdowns.

Read these and more top stories in endocrinology below:

Extra insulin supplies, medications advised for people with diabetes in wake of COVID-19

As the country struggles to come up with a public health response to the novel coronavirus pandemic, endocrinologists are warning people with type 1 and type 2 diabetes of their increased susceptibility for contracting the disease and how to best be prepared with an adequate supply of diabetes medications and testing supplies. Read more.

‘Your destiny is revealed to you:’ Match Day 2020 amid COVID-19

With rising infection rates in the United States constituting a national emergency, COVID-19 continues to affect all facets of life through institutional shutdowns, numerous lockdowns and the cancellation of many milestone events. Of the many event cancellations impacting the medical community, Match Day 2020 is challenging medical students and leaders alike to explore a new landscape for celebration, shedding light on the bigger picture of what it truly means to work in the medical field amid largescale pandemics. Read more.

COVID-19 Diabetes Infographic 
Experts are warning patients with type 1 and type 2 diabetes of their increased susceptibility to COVID-19 and are recommending that they keep an adequate supply of medication to be better prepared.
Source: Healio

‘Baptism by fire:’ Managing diabetes during COVID-19 in Seattle

As COVID-19 spreads across the country, the greater Seattle area has been one of the hardest-hit areas. Read more.

FDA: Suspend SGLT2 inhibitors before surgery

The FDA approved safety labeling changes for all SGLT2 inhibitors, recommending temporary discontinuation of the medications before any scheduled surgery to avoid potential risk for diabetic ketoacidosis, according to an agency press release. Read more.

Immune profiles reveal two distinct endotypes in type 1 diabetes

Clear phenotypic differences can be detected in the pancreases of children with type 1 diabetes when stratified by age at diagnosis, according to findings published in Diabetologia. Read more.

Experts are warning patients with type 1 and type 2 diabetes of their increased susceptibility to COVID-19 and are recommending that they keep an adequate supply of medication to be better prepared. It was the top story in endocrinology last week.

Another top story was about how medical students are celebrating Match Day 2020 amid institutional shutdowns.

Read these and more top stories in endocrinology below:

Extra insulin supplies, medications advised for people with diabetes in wake of COVID-19

As the country struggles to come up with a public health response to the novel coronavirus pandemic, endocrinologists are warning people with type 1 and type 2 diabetes of their increased susceptibility for contracting the disease and how to best be prepared with an adequate supply of diabetes medications and testing supplies. Read more.

‘Your destiny is revealed to you:’ Match Day 2020 amid COVID-19

With rising infection rates in the United States constituting a national emergency, COVID-19 continues to affect all facets of life through institutional shutdowns, numerous lockdowns and the cancellation of many milestone events. Of the many event cancellations impacting the medical community, Match Day 2020 is challenging medical students and leaders alike to explore a new landscape for celebration, shedding light on the bigger picture of what it truly means to work in the medical field amid largescale pandemics. Read more.

COVID-19 Diabetes Infographic 
Experts are warning patients with type 1 and type 2 diabetes of their increased susceptibility to COVID-19 and are recommending that they keep an adequate supply of medication to be better prepared.
Source: Healio

‘Baptism by fire:’ Managing diabetes during COVID-19 in Seattle

As COVID-19 spreads across the country, the greater Seattle area has been one of the hardest-hit areas. Read more.

FDA: Suspend SGLT2 inhibitors before surgery

The FDA approved safety labeling changes for all SGLT2 inhibitors, recommending temporary discontinuation of the medications before any scheduled surgery to avoid potential risk for diabetic ketoacidosis, according to an agency press release. Read more.

Immune profiles reveal two distinct endotypes in type 1 diabetes

Clear phenotypic differences can be detected in the pancreases of children with type 1 diabetes when stratified by age at diagnosis, according to findings published in Diabetologia. Read more.